Assessment of optimal protein dosage for maintaining and synthesizing muscle volume in inpatients with type 2 diabetes: Randomized Controlled Trial
Not Applicable
Recruiting
- Conditions
- patients with type 2 diabetes
- Registration Number
- JPRN-UMIN000047180
- Lead Sponsor
- Kyushu Nutrition Welfare University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Not provided
Exclusion Criteria
.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Muscle volume increasing ratio between the two groups: High dose group; protein dose of 1.3 g / ideal body weight (kg) or more vs. Low dose group; protein dose of less than 1.3 g / ideal body weight (kg)
- Secondary Outcome Measures
Name Time Method Divide the protein dose into ~ 0.9 / 1.0 / 1.1 / 1.2 / 1.3 / 1.4 / 1.5g / kg ~ to determine at which dose muscle volume changes from loss to increase.